11,975
Total Claims
$2.4M
Drug Cost
1,482
Beneficiaries
$1,633
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+7%
Cost per patient vs peers
$1,633 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 10,185 claims · $243K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 733 | $986K |
| Rivaroxaban | 207 | $294K |
| Macitentan | 23 | $281K |
| Sacubitril/Valsartan | 113 | $190K |
| Evolocumab | 199 | $164K |
| Alirocumab | 92 | $65K |
| Dapagliflozin Propanediol | 49 | $60K |
| Rosuvastatin Calcium | 2,142 | $44K |
| Ticagrelor | 46 | $41K |
| Ezetimibe | 295 | $13K |
| Potassium Chloride | 515 | $12K |
| Metoprolol Succinate | 680 | $12K |
| Atorvastatin Calcium | 724 | $9,989 |
| Evolocumab | 11 | $9,742 |
| Icosapent Ethyl | 12 | $9,415 |
Prescribing Profile
70
Unique Drugs
$1.5M
Patient Profile
77
Avg Age
54%
Female
1.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About